Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Mikkel Krogh-MadsenJenny Dahl Knudsen

Abstract

Consecutive Candida glabrata isolates recovered from a patient in an intensive care unit were resistant to amphotericin B (minimum inhibitory concentration, up to 32 mu g/mL; determined by Etest [AB Biodisk]). Analyses at the national reference laboratory showed that some isolates were also resistant to azoles and caspofungin. In this study, 4 isolates were studied thoroughly using susceptibility assays and a mouse model and to determine clonality. Different broth microdilution tests, Etests, and time-kill studies for antifungals were performed in different media. Three of the 4 isolates were examined in an in vivo experiment, in which mice were challenged intravenously with 1 of 3 isolates and treated daily with amphotericin B, caspofungin, or saline. For the clonality studies, arbitrarily primed polymerase chain reaction (PCR) was performed with the 4 isolates, 8 isolates obtained from nonrelated patients, and a reference strain. The murine model indicated that 1 isolate was resistant to amphotericin B, 1 had intermediate susceptibility, and 1 was fully susceptible. Two of the 3 isolates were resistant to caspofungin. Microdilution methods did not reliably differentiate between amphotericin B-susceptible and -resistant isolat...Continue Reading

References

Dec 1, 1990·Molecular and Cellular Probes·K H Rand, H Houck
Apr 1, 1995·Antimicrobial Agents and Chemotherapy·J H RexE J Anaissie
Jan 9, 1998·Microbiology·Shawn R LockhartDavid R Sol
Jan 13, 1999·Diagnostic Microbiology and Infectious Disease·M A PfallerA Bolmström
May 1, 1999·Antimicrobial Agents and Chemotherapy·R S LiaoJ A Talbot
Dec 26, 2001·The Journal of Antimicrobial Chemotherapy·A K Morris, R G Masterton
Apr 15, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J S OxfordR Lambkin
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Emilia CantónAna Espinel-Ingroff
Jan 11, 2005·Current Opinion in Infectious Diseases·David Andes
May 28, 2005·Expert Review of Anti-infective Therapy·Winter J GibbsJohn R Perfect

❮ Previous
Next ❯

Citations

Oct 27, 2006·Current Infectious Disease Reports·Katherine S Barker, P David Rogers
Feb 11, 2011·Current Infectious Disease Reports·Maurizio SanguinettiBrunella Posteraro
May 26, 2009·Revista iberoamericana de micología·Guillermo QuindósJavier Pemán
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luis Ostrosky-Zeichner
Mar 26, 2010·The Journal of Antimicrobial Chemotherapy·Melanie W PoundRichard H Drew
Jun 29, 2006·Current Opinion in Infectious Diseases·Georgios Chamilos, Dimitrios P Kontoyiannis
Jul 23, 2008·Antimicrobial Agents and Chemotherapy·Maiken Cavling ArendrupCornelia Lass-Flörl
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Santosh KatiyarThomas Edlind
Dec 15, 2010·Antimicrobial Agents and Chemotherapy·Sofia Costa-de-OliveiraCidália Pina-Vaz
Sep 15, 2010·Antimicrobial Agents and Chemotherapy·Alicia J ZimbeckShawn R Lockhart
Sep 17, 2008·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdSamuel A Lee
Oct 24, 2012·Antimicrobial Agents and Chemotherapy·Rasmus Hare JensenMaiken Cavling Arendrup
Apr 2, 2008·Antimicrobial Agents and Chemotherapy·John D ClearyDavid S Perlin
Apr 14, 2010·Antimicrobial Agents and Chemotherapy·D AndesA Lepak
Apr 20, 2011·Antimicrobial Agents and Chemotherapy·Nathan P WiederholdThomas F Patterson
Jan 16, 2007·Clinical Microbiology Reviews·M A Pfaller, D J Diekema
Oct 23, 2012·Eukaryotic Cell·Sara E Beese-SimsDavid E Levin
May 2, 2008·Journal of Clinical Microbiology·Marie Desnos-OllivierEric Dannaoui
Apr 11, 2008·Journal of Clinical Microbiology·Steven D Brown, Maria M Traczewski
Apr 28, 2010·Journal of Clinical Microbiology·Christopher D PfeifferBarbara D Alexander
Apr 14, 2011·European Journal of Medical Research·C RodloffR Schaumann
Apr 5, 2008·PLoS Pathogens·Louise A WalkerNeil A R Gow
Jan 1, 2009·Infection and Drug Resistance·Diane M Cappelletty, Rose Jung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.